First Manhattan CO Adamis Pharmaceuticals Corp Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$0.7 - $1.46 $974,213 - $2.03 Million	-1,391,733 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$1.26 - $2.23 $2.47 Million - $4.37 Million	-1,960,600 Reduced 58.48%	1,391,733 $1.81 Million
Q1 2019 Apr 12, 2019	SELL	$2.02 - $3.22 $135,210 - $215,533	-66,936 Reduced 1.96%	3,352,333 $7.07 Million
Q3 2018 Oct 15, 2018	BUY	$2.25 - $4.8 $7.69 Million - $16.4 Million	3,419,269 New	3,419,269 $12 Million

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.